Mobia Medical Inc MOBI
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
Mobia Medical Reports Third Quarter 2026 Financial Results
Mobia Medical to Participate in the 8th Annual Wolfe Research Healthcare Conference
Mobia Medical to Report Third Quarter 2026 Financial Results on November 5, 2026
Mobia Medical Announces Addition of Paired VNS to Updated AHA Stroke Guidelines
Mobia Medical Reports Second Quarter 2026 Financial Results
Trading Information
- Previous Close Price
- $11.28
- Day Range
- $10.95–11.51
- 52-Week Range
- $8.04–15.25
- Bid/Ask
- $11.01 / $11.53
- Shares Outstanding
- 33.29M
- Market Cap
- $376.52M
- Volume/Avg
- 18,478 / 203,866
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 4.12
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Mobia Medical Inc is a commercial-stage medical device company redefining stroke recovery for survivors living with life-altering motor impairments. The company develops, markets and sells devices for the treatment of medical conditions. Its flagship device is the Vivistim Paired Vagus Nerve Stimulation system, which is used to support motor function rehabilitation in patients with chronic ischemic stroke. The company generates all of its revenue from the sale of the Vivistim System to customers, mainly primary and comprehensive stroke centers, in the United States.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- —
- Total Number of Employees
- —
- Website
- https://www.mobia.com
Valuation
Metric | MOBI |
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 2.18 |
Price/Sales | 4.12 |
Price/Cash Flow | — |
Price/Earnings
MOBI
Financial Strength
Metric | MOBI |
|---|---|
Quick Ratio | 12.63 |
Current Ratio | 13.28 |
Interest Coverage | −57.39 |
Quick Ratio
MOBI
Profitability
Metric | MOBI |
|---|---|
Return on Assets (Normalized) | −58.93% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
MOBI
Medical Devices Industry Comparables
1-Day Chart | Name | Price | Morningstar Rating for Stocks | Capital Allocation | Economic Moat | Market Cap |
|---|---|---|---|---|---|---|
| Abbott Laboratories ABT | LOCK|<B#@TZ | LOCK|?&k!@ | $197B | |||
| Medtronic PLC MDT | LOCK|p?qjx% | LOCK|h&>?? | $134B | |||
| Stryker Corp SYK | LOCK|d?TRsr<x | LOCK|<<b | $128B | |||
| Boston Scientific Corp BSX | LOCK|fzj>%j | LOCK|&G^? | $65B | |||
| Edwards Lifesciences Corp EW | LOCK|<TVl%tZ< | LOCK|FQR% | $58B | |||
| GE HealthCare Technologies Inc Common Stock GEHC | LOCK|!!x!?V | LOCK|$H | $38B | |||
| DexCom Inc DXCM | LOCK|w>%^qhP# | LOCK|r?tn< | $31B | |||
| Koninklijke Philips NV ADR PHG | LOCK|>wh | LOCK|Vvv | $30B | |||
| Steris PLC STE | LOCK|K^HDnf% | LOCK|ct>Y | $25B | |||
| Zimmer Biomet Holdings Inc ZBH | LOCK|P@gLhRY | LOCK|?h | $20B |
United States